Denied

No. 17-351

Bais Yaakov of Spring Valley, et al. v. Federal Communications Commission, et al.

from the United States Court of Appeals for the District of Columbia Circuit

See other cases from the District of Columbia Circuit.

Docket Entries

Petition DENIED. Justice Alito took no part in the consideration or decision of this petition.

DISTRIBUTED for Conference of 2/16/2018.

Reply of petitioners Bais Yaakov of Spring Valley, et al. filed.

Brief of Private Respondents Anda, Inc., et al. in opposition filed.

Brief of Federal Respondents in opposition filed.

Motion to extend the time to file a response is granted and the time is further extended to and including January 16, 2018, for all respondents.

Motion to extend the time to file a response from January 2, 2018 to January 16, 2018, submitted to The Clerk.

Response Requested. (Due November 30, 2017)

DISTRIBUTED for Conference of 11/9/2017.

Waiver of right of respondents Staples, Inc; Quill Corp. to respond filed.

Waiver of right of respondent Merck & Company, Inc. to respond filed.

Waiver of right of respondent ZocDoc, Inc. to respond filed.

Waiver of right of respondent Anda, Inc. to respond filed.

Waiver of right of respondent TechHealth, Inc. to respond filed.

Waiver of right of respondents Douglas P. Walburg and Richie Enterprise, LLC to respond filed.

Waiver of right of respondents FCC, et al. to respond filed.

Petition for a writ of certiorari filed. (Response due October 10, 2017)

Parties

Bais Yaakov of Spring Valley, et al., Petitioner, represented by Aytan Yehoshua Bellin

Douglas P. Walburg and Richie Enterprise, LLC, Respondent, represented by Matthew Eben Price

Federal Respondents, Respondent, represented by Noel J. Francisco

Forest Pharmaceuticals, Inc.; Gilead Palo Alto, Inc.; Gilead Sciences, Inc.; Masimo Corp.; Purdue Pharma LP; Purdue Pharma, Inc; Pursue Products LP; Unique Vacations, Inc., Respondent, represented by Robert Allen Long Jr.

Merck & Company, Inc., Respondent, represented by Kim Elizabeth Rinehart

ZocDoc, Inc., Respondent, represented by Blaine Christopher Kimrey

 
Last updated: November 23, 2024